IFLR1000

TPG Capital $135 million acquisition of Sai Life Sciences

30/7/2018
Private acquisition
Select tab

Af 135 million

Announced

30/7/2018

Overview:

  • TPG Capital will acquire Tata Capital's 33% stake in Sai Life Sciences.

Daniel Semerdzhiev - Data analyst

Jurisdiction:

India

Deal type:

Private acquisition

Practice area:

M&A

Governing law:

India

Industry sector:

Pharmaceuticals and life sciences

Firms:
Cyril Amarchand Mangaldas

Party: Sai Life Sciences Ltd (Target)

Shardul Amarchand Mangaldas & Co

Party: TPG Capital (Acquirer)

Touchstone Partners

Party: Tata Capital Ltd (Seller)

Related deals